Airway Management of Critically Ill Pediatric Patients with Suspected or Proven Coronavirus Disease 2019 Infection:

Franco Díaz1,2,3, Pablo Cruces1,3,4

  • 1Unidad de Paciente Crítico Pediátrico, Hospital el Carmen de Maipú, Santiago, Chile.

Insights

Advanced airway management, including endotracheal intubation, is critical for critically ill children with COVID-19. This article details the unique challenges and considerations for pediatric intubation during the pandemic.

Area of Science:

  • Pediatric Critical Care Medicine
  • Infectious Diseases
  • Respiratory Medicine

Background:

  • Critically ill children with COVID-19 require advanced airway management, particularly endotracheal intubation, for conditions like shock or respiratory failure.
  • Pediatric intubation presents unique physiological and pathophysiological challenges, amplified by airborne pathogens such as SARS-CoV-2.
  • Existing COVID-19 guidelines offer limited in-depth guidance on endotracheal intubation for acutely ill children.

Purpose of the Study:

  • To highlight the specific challenges and potential pitfalls of endotracheal intubation in critically ill pediatric patients with COVID-19.
  • To provide a focused discussion on advanced airway management strategies relevant to pediatric COVID-19 cases.
  • To address the gap in current literature regarding pediatric endotracheal intubation during the COVID-19 pandemic.

Main Methods:

  • Review and synthesis of existing literature on pediatric airway management.
  • Analysis of physiological and pathophysiological factors influencing pediatric intubation in the context of COVID-19.
  • Discussion of clinical considerations and potential complications specific to pediatric endotracheal intubation during the pandemic.

Main Results:

  • Endotracheal intubation in critically ill children with COVID-19 is complex due to pediatric-specific physiology and disease pathophysiology.
  • Airborne pathogen presence, like SARS-CoV-2, adds significant risk to the intubation procedure.
  • Current pediatric COVID-19 guidelines lack detailed recommendations for endotracheal intubation.

Conclusions:

  • Advanced airway management, specifically endotracheal intubation, is a critical yet challenging aspect of pediatric intensive care unit care for COVID-19 patients.
  • There is a need for more detailed, evidence-based guidelines addressing the nuances of endotracheal intubation in critically ill children during infectious disease outbreaks.
  • Understanding the unique challenges is essential for optimizing patient outcomes and ensuring safe intubation practices in pediatric COVID-19 cases.

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
137
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.0K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
324
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
204
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
184
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
222